The study suggested that these optimization issues were routine problems that a structured pharmacist review could surface.

• A. False; they were rare and not detectable
• B. True; they were routine optimization problems that a structured pharmacist review could surface
• C. True; but only with automated systems
• D. False; they were not related to therapy

Answer: (B)

A structured pharmacist review uses a systematic, checklist-like approach to examine a patient’s therapy and quickly spot common opportunities for improvement. The statement reflects that these optimization issues appear regularly in practice, not as rare exceptions, so a careful, organized review will surface them routinely. Think of it as having a consistent process that looks for dosing mismatches, unnecessary duplications, suboptimal therapy choices, safety concerns, and adherence gaps—things that tend to pop up across many patients when you apply the same criteria each time.

This is why the best interpretation is that the issues are routine and detectable through a structured review. It isn’t about needing automated systems to find them, and it isn’t about these problems being unrelated to therapy—both of those ideas don’t fit with the idea that a standard pharmacist review can surface them regularly.